Compare Biocon with STRIDES PHARMA SCIENCE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs STRIDES PHARMA SCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON STRIDES PHARMA SCIENCE BIOCON /
STRIDES PHARMA SCIENCE
 
P/E (TTM) x 49.3 183.5 26.9% View Chart
P/BV x 6.1 2.0 307.8% View Chart
Dividend Yield % 0.0 0.4 -  

Financials

 BIOCON    STRIDES PHARMA SCIENCE
EQUITY SHARE DATA
    BIOCON
Mar-21
STRIDES PHARMA SCIENCE
Mar-21
BIOCON /
STRIDES PHARMA SCIENCE
5-Yr Chart
Click to enlarge
High Rs4881,000 48.8%   
Low Rs275304 90.4%   
Sales per share (Unadj.) Rs59.2369.7 16.0%  
Earnings per share (Unadj.) Rs7.739.6 19.5%  
Cash flow per share (Unadj.) Rs13.762.6 21.8%  
Dividends per share (Unadj.) Rs02.50 0.0%  
Avg Dividend yield %00.4 0.0%  
Book value per share (Unadj.) Rs62.3309.1 20.1%  
Shares outstanding (eoy) m1,200.0089.68 1,338.1%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x6.41.8 365.0%   
Avg P/E ratio x49.416.4 300.6%  
P/CF ratio (eoy) x27.910.4 267.9%  
Price / Book Value ratio x6.12.1 290.2%  
Dividend payout %06.3 0.0%   
Avg Mkt Cap Rs m457,35058,465 782.3%   
No. of employees `000NANA-   
Total wages/salary Rs m17,4105,501 316.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m71,05833,159 214.3%  
Other income Rs m6,052734 824.7%   
Total revenues Rs m77,11033,893 227.5%   
Gross profit Rs m13,1456,702 196.1%  
Depreciation Rs m7,1512,063 346.7%   
Interest Rs m5771,501 38.5%   
Profit before tax Rs m11,4693,872 296.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,215317 699.8%   
Profit after tax Rs m9,2543,555 260.3%  
Gross profit margin %18.520.2 91.5%  
Effective tax rate %19.38.2 236.3%   
Net profit margin %13.010.7 121.5%  
BALANCE SHEET DATA
Current assets Rs m76,00428,172 269.8%   
Current liabilities Rs m42,10127,383 153.7%   
Net working cap to sales %47.72.4 2,005.5%  
Current ratio x1.81.0 175.5%  
Inventory Days Days137165 82.7%  
Debtors Days Days63122 51.3%  
Net fixed assets Rs m106,14239,996 265.4%   
Share capital Rs m6,000897 669.0%   
"Free" reserves Rs m68,72826,823 256.2%   
Net worth Rs m74,72827,719 269.6%   
Long term debt Rs m29,6168,826 335.6%   
Total assets Rs m182,14668,168 267.2%  
Interest coverage x20.93.6 583.1%   
Debt to equity ratio x0.40.3 124.5%  
Sales to assets ratio x0.40.5 80.2%   
Return on assets %5.47.4 72.8%  
Return on equity %12.412.8 96.5%  
Return on capital %11.514.7 78.5%  
Exports to sales %051.1 0.0%   
Imports to sales %7.20-   
Exports (fob) Rs mNA16,941 0.0%   
Imports (cif) Rs m5,084NA-   
Fx inflow Rs m11,79135,084 33.6%   
Fx outflow Rs m5,084392 1,297.3%   
Net fx Rs m6,70734,692 19.3%   
CASH FLOW
From Operations Rs m11,5974,814 240.9%  
From Investments Rs m-36,247-5,208 696.0%  
From Financial Activity Rs m25,640-158 -16,232.0%  
Net Cashflow Rs m723-564 -128.2%  

Share Holding

Indian Promoters % 39.7 29.4 135.4%  
Foreign collaborators % 20.9 0.3 7,744.4%  
Indian inst/Mut Fund % 23.4 40.4 58.0%  
FIIs % 15.9 25.8 61.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.4 70.4 55.9%  
Shareholders   338,827 96,976 349.4%  
Pledged promoter(s) holding % 0.0 26.3 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   HIKAL.  ERIS LIFESCIENCES  ANUH PHARMA  KIMIA BIOSCIENCES  PROCTER & GAMBLE HEALTH  



Today's Market

Sensex Slumps 700 Points from Day's High to End Lower; Tata Steel & SBI Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

BIOCON 2020-21 Annual Report Analysis (Annual Result Update)

Aug 10, 2021 | Updated on Aug 10, 2021

Here's an analysis of the annual report of BIOCON for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of BIOCON . Also includes updates on the valuation of BIOCON .

STRIDES PHARMA SCIENCE Announces Quarterly Results (1QFY22); Net Profit Down 253.9% (Quarterly Result Update)

Aug 9, 2021 | Updated on Aug 9, 2021

For the quarter ended June 2021, STRIDES PHARMA SCIENCE has posted a net profit of Rs 2 bn (down 253.9% YoY). Sales on the other hand came in at Rs 7 bn (down 12.0% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

BIOCON Announces Quarterly Results (1QFY22); Net Profit Down 4.0% (Quarterly Result Update)

Jul 26, 2021 | Updated on Jul 26, 2021

For the quarter ended June 2021, BIOCON has posted a net profit of Rs 2 bn (down 4.0% YoY). Sales on the other hand came in at Rs 18 bn (up 3.9% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

BIOCON Announces Quarterly Results (4QFY21); Net Profit Up 118.6% (Quarterly Result Update)

Jul 8, 2021 | Updated on Jul 8, 2021

For the quarter ended March 2021, BIOCON has posted a net profit of Rs 4 bn (up 118.6% YoY). Sales on the other hand came in at Rs 18 bn (up 16.3% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

STRIDES PHARMA SCIENCE Announces Quarterly Results (3QFY21); Net Profit Down 46.4% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, STRIDES PHARMA SCIENCE has posted a net profit of Rs 621 m (down 46.4% YoY). Sales on the other hand came in at Rs 8 bn (up 13.6% YoY). Read on for a complete analysis of STRIDES PHARMA SCIENCE's quarterly results.

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider(Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore(Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market(Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Sep 17, 2021 (Close)

TRACK BIOCON

BIOCON - CORAL LAB. COMPARISON

COMPARE BIOCON WITH

MARKET STATS